A 24‐week Multicentre, Randomised, Open‐label, Parallel‐group Study Comparing the Efficacy and Safety of Ixekizumab to Fumaric Acid Esters and Methotrexate in Patients With Moderate‐to‐severe Plaque Psoriasis Naïve to Systemic Treatment
British Journal of Dermatology - United Kingdom
doi 10.1111/bjd.18384
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2020
Authors
Publisher
Wiley